Company Filing History:
Years Active: 1998-1999
Title: Nancy Jones: Innovator in Monoclonal Antibodies
Introduction
Nancy Jones is a prominent inventor based in Wayland, MA (US), known for her contributions to the field of immunotherapy. With a total of 2 patents, she has made significant strides in the development of monoclonal antibodies, particularly in the diagnosis and treatment of autoimmune diseases.
Latest Patents
Her latest patent focuses on the therapy of sarcoidosis through monoclonal antibodies that are reactive with an epitope of a V.beta.3.1 variable. This invention is directed towards monoclonal antibodies that specifically target the V.beta.3 family variable region of the beta chain of the T cell receptor (TCR). Notably, the invention allows for the detection of the V.beta.3.1 subfamily without cross-reacting with other V.beta.3 family variable regions. The monoclonal antibodies, designated as 5E4 and 8F10, are particularly useful for diagnosing and treating autoimmune diseases, including rheumatoid arthritis.
Career Highlights
Throughout her career, Nancy has worked with notable companies such as Astra Ab and Avant Immunotherapeutics, Inc. Her work has been instrumental in advancing therapeutic options for patients suffering from autoimmune conditions.
Collaborations
Nancy has collaborated with esteemed colleagues, including Charles William Rittershaus and Patrick C Kung, contributing to the innovative research in her field.
Conclusion
Nancy Jones stands out as a dedicated inventor whose work in monoclonal antibodies has the potential to transform the landscape of autoimmune disease treatment. Her contributions continue to pave the way for future advancements in immunotherapy.